Company profile

Specialist in treatment of iron deficiency anaemia and clinical grade dextran biopolymers

Pharmacosmos is a privately-owned, specialist pharmaceutical company established in 1965 by Dr. Henry M. Christensen M.D. and is specialized in:

  1. Treatment of iron deficiency anaemia in humans
  2. Treatment of iron deficiency anaemia in animals
  3. High quality, clinical grade dextran biopolymers

Our corporate headquarter is located in Denmark, Scandinavia, where we manufacture and develop treatments of iron deficiency anemia in humans and animals.

Specialist in iron therapy

A leading specialist in intravenous iron therapy, we market our pharmaceuticals products for treatment of iron deficiency anaemia, Monofer® (iron isomaltoside 1000) and Cosmofer® (low molecular weight iron dextran), in more than 45 countries worldwide.

Our veterinary product, Uniferon® (iron dextran) is the only treatment and prevention of iron deficiency in animals approved by health authorities in Europe, Asia and by FDA in the US.

Clinical grade dextran biopolymers

Our second focus area, Pharmacosmos is the leading manufacturer of high quality, clinical grade dextran biopolymers.

Learn more about our products for treatments of iron deficiency anaemia and clinical grade dextran biopolymers.

Or read about Pharmacosmos Board of Directors.